Abstract
In the present report, a concise synthesis of viscolin (1) has been achieved. The anti-inflammatory effect of viscolin was investigated in vitro and in vivo. Viscolin blocked the expression of iNOS and COX-2, and it also inhibited the ERK for the activation of NF-κB in LPS-stimulated RAW 264.7 macrophages. Western blotting and immunohistochemical analysis revealed that viscolin decreased Carr-induced iNOS and COX-2 expressions. These results could help to deduce the anti-inflammatory mechanisms.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Anti-Inflammatory Agents / chemical synthesis*
-
Anti-Inflammatory Agents / pharmacology
-
Biphenyl Compounds / chemical synthesis*
-
Biphenyl Compounds / pharmacology*
-
Blotting, Western
-
Cell Line
-
Cyclooxygenase 2 / metabolism
-
Dinoprostone / antagonists & inhibitors
-
Dinoprostone / metabolism
-
Edema / drug therapy
-
Extracellular Signal-Regulated MAP Kinases / antagonists & inhibitors
-
Extracellular Signal-Regulated MAP Kinases / metabolism
-
Immunohistochemistry
-
Macrophages / drug effects
-
Macrophages / metabolism
-
Mice
-
Nitric Oxide Synthase Type II / antagonists & inhibitors
-
Nitric Oxide Synthase Type II / metabolism
-
Propane / analogs & derivatives*
-
Propane / chemical synthesis
-
Propane / pharmacology
-
Tumor Necrosis Factor-alpha / antagonists & inhibitors
-
Tumor Necrosis Factor-alpha / metabolism
Substances
-
Anti-Inflammatory Agents
-
Biphenyl Compounds
-
Tumor Necrosis Factor-alpha
-
viscolin
-
Nitric Oxide Synthase Type II
-
Cyclooxygenase 2
-
Extracellular Signal-Regulated MAP Kinases
-
Dinoprostone
-
Propane